Are better days ahead for Indian pharma industry? Your views?
Asked by Good Citizen, 02 Aug '10 04:36 pm
Earn 10 points for answering
Yes, The Indian pharmaceutical industry is also getting increasingly U.S. FDA compliant to harness the growth opportunities in areas of contract manufacturing and research. Indian companies such as Ranbaxy, Sun Pharma, and Dr. Reddy's are increasingly focusing on tapping the U.S. generic market, projected to be around $18 billion by 2004.Answered by venkatesaldevarajan, 03 Aug '10 10:17 am
Your vote on this answer has already been received